ArticleACS pharmacology & translational science2024

Energy Blocker Lonidamine Reverses Nimustine Resistance in Human Glioblastoma Cells through Energy Blockade, Redox Homeostasis Disruption, and

Yaxing Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.